552 Pill - blue capsule/oblong, 14mm
Pill with imprint 552 is Blue, Capsule/Oblong and has been identified as Minocycline Hydrochloride Extended-Release 105 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc.
Minocycline is used in the treatment of Bacterial Infection; Acne; Bullous Pemphigoid; Bartonellosis; Actinomycosis and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Minocycline 105 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 552
Minocycline Hydrochloride Extended-Release
- Imprint
- 552
- Strength
- 105 mg
- Color
- Blue
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Tetracyclines
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zydus Pharmaceuticals (USA) Inc.
- Manufacturer
- Cadila Healthcare Limited
- National Drug Code (NDC)
- 70771-1157
- Inactive Ingredients
-
silicon dioxide,
FD&C Blue No. 2,
FD&C Red No. 40,
hypromelloses,
lactose monohydrate,
magnesium stearate,
polyethylene glycol 3350,
titanium dioxide,
triacetin
Note: Inactive ingredients may vary.
Related images for "552"
More about minocycline
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (564)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: tetracyclines
- Breastfeeding
- En español
Patient resources
- Minocycline drug information
- Minocycline (Intravenous) (Advanced Reading)
- Minocycline Capsules and Tablets
- Minocycline Extended-Release Tablets
Other brands
Minocin, Emrosi, Dynacin, Ximino, ... +3 more
Professional resources
- Minocycline monograph
- Minocycline (EENT) (AHFS Monograph)
- Minocycline (FDA)
- Minocycline Capsules (FDA)
- Minocycline Extended Release Tablets (FDA)
Other brands
Minocin, Emrosi, Minocin for Injection, Ximino, ... +2 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.